Basit öğe kaydını göster

dc.contributor.authorGümüş, Aziz
dc.contributor.authorÖzkaya, Şevket
dc.contributor.authorÖzyurt, Songül
dc.contributor.authorÇınarka, Halit
dc.contributor.authorKırbaş, Aynur
dc.contributor.authorŞahin, Ünal
dc.contributor.authorEce, Ferah
dc.date.accessioned2020-12-19T20:15:48Z
dc.date.available2020-12-19T20:15:48Z
dc.date.issued2014
dc.identifier.citationGumus, A., Ozkaya, S., Ozyurt, S., Cinarka, H., Kirbas, A., Sahin., U., Ece, F., (2014). A novel biomarker in the diagnosis of parapneumonic effusion: neutrophil gelatinase-associated lipocalin. Multidisciplinary Respiratory Medicine, 9, article number 49. https://doi.org/10.1186/2049-6958-9-49
dc.identifier.issn1828-695X
dc.identifier.urihttps://doi.org/10.1186/2049-6958-9-49
dc.identifier.urihttps://hdl.handle.net/11436/4037
dc.description.abstractBackground: The protein neutrophil gelatinase-associated lipocalin (NGAL) is a mediator synthesized and released by neutrophils. Its physiological function is as yet unclear. Levels in blood increase in several inflammatory diseases. High serum values indicate poor prognosis for several diseases. Pleural effusion may appear as the result of various pathologies. The most common cause is heart failure (HF). Other common causes include parapneumonic (PPE) and malignant (MPE) pleural effusions, and pulmonary embolism. Tubercular effusion (TE) is commonly encountered in Turkey and similar developing countries. The purpose of this study was to investigate the effectiveness of NGAL, a current inflammation marker, in discriminating between different etiological diseases that cause pleural effusion. Methods: The study was performed at the Recep Tayyip Erdoğan University Faculty of Medicine Chest Diseases Clinic. One hundred patients were included in the study, 25 with parapneumonic effusion, 25 with heart failure-related effusion, 25 with tubercular effusion and 25 with cancer-related effusion. NGAL was measured in patients' serum and pleural fluids. Results: Serum NGAL levels in PPE (171 ± 56 ng/ml) were significantly higher (p < 0.001) than those in HF (86 ± 31 ng/ml), CA (103 ±42 ng/ml) and TE (63 ± 19 ng/ml). Pleural NGAL levels were also significantly higher in PPE compared to HF, MPE and TE (p < 0.001). Serum NGAL levels exhibited a positive correlation with white blood cel (WBC), neutrophil, C-reactive protein (CRP), sedimentation, serum LDH, creatinine, pleural leukocyte and pleura neutrophil numbers. The most significant correlation was between NGAL level and WBC (p < 0.001, r= 0.579). Both serum and pleural NGAL levels are highly effective in differentiating patients with PPE from those without PPE (AUC: 0.910 and 0.790, respectively). Conclusions: NGAL can be used in the diagnosis of diseases with an acute inflammatory course. Serum and pleural NGAL levels can differentiate PPE from other diseases causing pleural fluid with high sensitivity and specificity. © 2014 Gümüs et al.en_US
dc.language.isoengen_US
dc.publisherBioMed Central Ltd.en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectNeutrophil gelatinase-associated lipocalinen_US
dc.subjectNGALen_US
dc.subjectParapneumonic effusionen_US
dc.subjectPleural effusionen_US
dc.titleA novel biomarker in the diagnosis of parapneumonic effusion: neutrophil gelatinase-associated lipocalinen_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorGümüş, Aziz
dc.contributor.institutionauthorÖzyurt, Songül
dc.contributor.institutionauthorÇınarka, Halit
dc.contributor.institutionauthorKırbaş, Aynur
dc.contributor.institutionauthorŞahin, Ünal
dc.identifier.doi10.1186/2049-6958-9-49
dc.identifier.volume9en_US
dc.identifier.issue1en_US
dc.relation.journalMultidisciplinary Respiratory Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster